Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | a disintegrin and metalloproteinase with | 0.6125 | 0.3671 | 0.0436 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.3546 | 0.1405 | 1 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.1947 | 0 | 0.5 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.7202 | 0.4617 | 0.1939 |
Brugia malayi | Hemopexin family protein | 0.2267 | 0.0281 | 0.0765 |
Schistosoma mansoni | ADAMTS5 peptidase (M12 family) | 0.6125 | 0.3671 | 0.3604 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.7202 | 0.4617 | 0.1847 |
Echinococcus granulosus | a disintegrin and metalloproteinase with | 0.6125 | 0.3671 | 0.0415 |
Echinococcus multilocularis | adam 17 protease | 1.2971 | 0.9688 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.3546 | 0.1405 | 1 |
Brugia malayi | Matrixin family protein | 0.3866 | 0.1686 | 0.4592 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 1.2971 | 0.9688 | 1 |
Loa Loa (eye worm) | hypothetical protein | 1.2457 | 0.9235 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.3866 | 0.1686 | 0.1826 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.1947 | 0 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.3546 | 0.1405 | 0.1521 |
Brugia malayi | metalloprotease disintegrin 16 with thrombospondin type I motif | 0.6125 | 0.3671 | 1 |
Mycobacterium ulcerans | hydrolase | 0.1947 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 64 % | Antiinflammatory activity in PMA-treated human THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 10 uM incubated for 24 hrs prior to LPS challenge measured after 24 hrs by ELISA relative to control | ChEMBL. | 23458950 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.